Osprey Medical Receives US FDA Clearance for DyeVert™ PLUS
Posted:
2017-03-09 in Press Releases
New drugs in development to starve cancer cells
Posted:
2017-03-07 in Press Releases
Global Kinetics Corporation Joins Quest to Predict Parkinson’s
Posted:
2017-01-31 in Press Releases
Osprey 4C Q4 2016 Cash Flow Report
Posted:
2017-01-30 in Press Releases
Auspherix Provides Update on its New Class of Organogold Antibiotics
Posted:
2017-01-05 in Press Releases
Global Kinetics and uMotif announce technology partnership for Parkinson’s trials
Posted:
2016-12-16 in Press Releases
Brandon Capital to lead Biomedical Translation Fund Consortium - major new Government initiative
Posted:
2016-12-13 in Press Releases
Management Team Strengthened as Auspherix Drives New Class of Antibacterials Towards the Clinic
Posted:
2016-11-17 in Press Releases
Osprey Introduces DyeVert PLUS at TCT
Posted:
2016-11-02 in Press Releases
Osprey Medical Inc. Releases Q3 2016 Cash Flow Results
Posted:
2016-10-14 in Press Releases